debt

Showing 1 posts of 1 posts found.

novartis_window

Novartis buys dry eye treatment Xiidra in deal worth $5.3 billion

May 9, 2019
Business Services, Medical Communications, Sales and Marketing Novartis, Shire, Takeda, debt, pharma, xiidra

Japanese multinational Takeda Pharmaceutical has agreed to sell its dry eye drug Xiidra to Swiss firm Novartis in a deal …

Latest content